Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-001669

Chief Medical Officer sold 849 shares at $4.06 ($3,451)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Norry Elliot Chief Medical Officer 2022-01-04 Sale −849 $4.06 $3,451 1,388 D
Open-market sales · 849 sh · avg $4.06 · $3,451
Loading xslF345X03/tm221700-2_4seq1.xml…